Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AB-free Kava for Mobility Loss in Aging
NCT07219186Phase 1Not yet recruiting
- Sponsor
- University of Florida
- Start
- Dec 2026
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Insomnia comparing AB-free Kava with Placebo (2 arms). Primary endpoints: 400-meter walk test at 8 weeks, Short Physical Performance Battery at 8 weeks and 1 more. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
AB-free kava
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT07219186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07219186.